Sonoma Pharmaceuticals, Inc.
SNOA
$2.75
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -22.39% | 39.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -22.39% | 39.58% | |||
| Cost of Revenue | -22.53% | 36.57% | |||
| Gross Profit | -22.17% | 44.81% | |||
| SG&A Expenses | -5.90% | -4.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.38% | 16.26% | |||
| Operating Income | -101.19% | 69.22% | |||
| Income Before Tax | -29.82% | 41.14% | |||
| Income Tax Expenses | 34.01% | -19,600.00% | |||
| Earnings from Continuing Operations | -53.37% | 56.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -53.37% | 56.97% | |||
| EBIT | -101.19% | 69.22% | |||
| EBITDA | -113.95% | 71.58% | |||
| EPS Basic | -47.38% | 57.10% | |||
| Normalized Basic EPS | -24.71% | 41.31% | |||
| EPS Diluted | -47.38% | 57.10% | |||
| Normalized Diluted EPS | -24.71% | 41.31% | |||
| Average Basic Shares Outstanding | 4.07% | 0.30% | |||
| Average Diluted Shares Outstanding | 4.07% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||